Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.450
+0.130 (3.92%)
At close: Oct 8, 2025, 4:00 PM EDT
3.410
-0.040 (-1.16%)
After-hours: Oct 8, 2025, 5:57 PM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$2,016,680
Market Cap
176.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | 13 | -1 | -7.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACHV News
- 6 days ago - Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewsWire
- 16 days ago - Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD - GlobeNewsWire
- 20 days ago - Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer - GlobeNewsWire
- 27 days ago - Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years - Benzinga
- 2 months ago - Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript - Seeking Alpha